Table 2.
n | % | |
---|---|---|
First-line drugs | ||
Intravenous immunoglobulins | 153 | 85 |
Steroids | 133 | 74 |
Plasma exchange | 22 | 12 |
Subcutaneous immunoglobulins | 15 | 8 |
Second-line drugs | ||
Azathioprine | 66 | 36 |
Mycophenolate mofetil | 38 | 21 |
Steroids (orally) | 30 | 17 |
Ciclosporin A | 24 | 13 |
Methotrexate | 6 | 3 |
Therapy regimens of 181 patients (90.5%) were available. |